Inheritance of the lysozyme inhibitor Ivy was an important evolutionary step by Yersinia pestis to avoid the host innate immune response

Journal of Infectious Diseases

Volumn 207, Issue 10, 2013, Pages 1535-1543

  Derbise, Anne ^e   Pierre, François ^a,b,c,d   Merchez, Maud ^a,b,c,d   Pradel, Elizabeth ^a,b,c,d   Laouami, Sabrina ^a,b,c,d   Ricard, Isabelle ^a,b,c,d   Sirard, Jean Claude ^b,c,d   Fritz, Jill ^g   Lemaître, Nadine ^a,b,c,d   Akinbi, Henry ^g   Boneca, Ivo G ^e,f   Sebbane, Florent ^a,b,c,d  

^a INSERM U1019   (France)

^b CNRS   (France)

^c INSTITUT PASTEUR DE LILLE   (France)

^d UNIV LILLE   (France)

^e INSTITUT PASTEUR   (France)

^f INSERM   (France)

^g CINCINNATI CHILDREN'S HOSPITAL MEDICAL CENTER   (United States)

Author keywords

Innate immunity; lysozyme; Plague; PMN; Yersinia; Yersiniosis

Indexed keywords

GLYCOSIDASE INHIBITOR; IVY PROTEIN; MLIC PROTEIN; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BACTERIAL GROWTH; BACTERIAL STRAIN; BACTERIAL VIRULENCE; BACTERIUM MUTANT; CONTROLLED STUDY; ENZYME DEFICIENCY; FEMALE; HOST PATHOGEN INTERACTION; HUMAN; HUMAN CELL; IN VITRO STUDY; IN VIVO STUDY; INFECTION RESISTANCE; INFLAMMATION; INHERITANCE; INNATE IMMUNITY; LEUKOCYTE; MACROPHAGE; MALE; MOLECULAR EVOLUTION; MOUSE; NEUTROPENIA; NEUTROPHIL; NONHUMAN; PATHOPHYSIOLOGY; PLAGUE; PRIORITY JOURNAL; PUNCH BIOPSY; RAT; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; WILD TYPE; YERSINIA PESTIS; YERSINIA PSEUDOTUBERCULOSIS; YERSINIA PSEUDOTUBERCULOSIS INFECTION;

ANIMALS; BACTERIAL PROTEINS; BLOOD; CATTLE; CELL LINE; ESCHERICHIA COLI; EVOLUTION, MOLECULAR; FEMALE; GENE DELETION; HUMANS; IMMUNITY, INNATE; MACROPHAGES; MALE; MICE; MICE, KNOCKOUT; MURAMIDASE; NEUTROPHILS; PERIPLASM; PHAGOCYTES; PLAGUE; RATS; RATS, INBRED BN; SERUM ALBUMIN, BOVINE; VIRULENCE; VIRULENCE FACTORS; YERSINIA PESTIS; YERSINIA PSEUDOTUBERCULOSIS; YERSINIA PSEUDOTUBERCULOSIS INFECTIONS;

EID: 84876554747     PISSN: 00221899     EISSN: None     Source Type: Journal    
DOI: 10.1093/infdis/jit057     Document Type: Article

References (50)

1. Butler T. Plague and Other Yersinia Infections. New and London: Plenum Medical Book Company, 1983.
2. Cornelis GR, Boland A, Boyd AP, et al. The virulence plasmid of Yersinia, an antihost genome. Microbiol Mol Biol Rev 1998; 62:1315-52. (Pubitemid 28558301)
3. Sebbane F, Lemaitre N, Sturdevant DE, et al. Adaptive response of Yersinia pestis to extracellular effectors of innate immunity during bubonic plague. Proc Natl Acad Sci USA 2006; 103:11766-71. (Pubitemid 44182525)
4. Sebbane F, Gardner D, Long D, Gowen BB, Hinnebusch BJ. Kinetics of disease progression and host response in a rat model of bubonic plague. Am J Pathol 2005; 166:1427-39. (Pubitemid 40586513)
5. Faurschou M, Borregaard N. Neutrophil granules and secretory vesicles in inflammation. Microbes Infect 2003; 5:1317-27. (Pubitemid 37410245)
6. Abergel C, Monchois V, Byrne D, et al. Structure and evolution of the Ivy protein family, unexpected lysozyme inhibitors in Gram-negative bacteria. Proc Natl Acad Sci USA 2007; 104:6394-9. (Pubitemid 47186105)
7. Cole AM, Dewan P, Ganz T. Innate antimicrobial activity of nasal secretions. Infection and Immunity 1999; 67:3267-75. (Pubitemid 29291490)
8. Hansen NE, Karle H, Andersen V. Lysozyme turnover in the rat. J Clin Invest 1971; 50:1473-7.
9. Gordon S, Todd J, Cohn ZA. In vitro synthesis and secretion of lysozyme by mononuclear phagocytes. J Exp Med 1974; 139:1228-48.
10. Rausch PG, Canonico PG. Characterization of monkey peripheral neutrophil granules during infection. Infection and Immunity 1975; 12:687-93.
11. Nash JA, Ballard TN, Weaver TE, Akinbi HT. The peptidoglycandegrading property of lysozyme is not required for bactericidal activity in vivo. J Immunol 2006; 177:519-26. (Pubitemid 43939165)
12. Masschalck B, Deckers D, Michiels CW. Lytic and nonlytic mechanism of inactivation of gram-positive bacteria by lysozyme under atmospheric and high hydrostatic pressure. J Food Prot 2002; 65: 1916-23. (Pubitemid 36017023)
13. Ganz T, Gabayan V, Liao HI, et al. Increased inflammation in lysozyme M-deficient mice in response to Micrococcus luteus and its peptidoglycan. Blood 2003; 101:2388-92. (Pubitemid 36302086)
14. Ellison RT 3rd, Giehl TJ. Killing of gram-negative bacteria by lactoferrin and lysozyme. J Clin Invest 1991; 88:1080-91.
15. Strominger JL, Ghuysen JM. Mechanisms of enzymatic bacteriaolysis. Cell walls of bacteri are solubilized by action of either specific carbohydrases or specific peptidases. Science 1967; 156:213-21.
16. Deckers D, Masschalck B, Aertsen A, et al. Periplasmic lysozyme inhibitor contributes to lysozyme resistance in Escherichia coli. Cell Mol Life Sci 2004; 61:1229-37. (Pubitemid 38703752)
17. Callewaert L, Aertsen A, Deckers D, et al. A new family of lysozyme inhibitors contributing to lysozyme tolerance in gram-negative bacteria. PLoS Pathogens 2008; 4:e1000019.
18. Uehara T, Suefuji K, Valbuena N, Meehan B, Donegan M, Park JT. Recycling of the anhydro-N-acetylmuramic acid derived from cell wall murein involves a two-step conversion to N-acetylglucosaminephosphate. J Bacteriol 2005; 187:3643-9. (Pubitemid 40705566)
19. Deckers D, Vanlint D, Callewaert L, Aertsen A, Michiels CW. Role of the lysozyme inhibitor Ivy in growth or survival of Escherichia coli and Pseudomonas aeruginosa bacteria in hen egg white and in human saliva and breast milk. Appl Environ Microbiol 2008; 74: 4434-9. (Pubitemid 352031025)
20. Daigle F, Graham JE, Curtiss R 3rd. Identification of Salmonella typhi genes expressed within macrophages by selective capture of transcribed sequences (SCOTS). Mol Microbiol 2001; 41:1211-22. (Pubitemid 36124714)
21. Clarke CA, Scheurwater EM, Clarke AJ. The vertebrate lysozyme inhibitor Ivy functions to inhibit the activity of lytic transglycosylase. J Biol Chem 2010; 285:14843-7.
22. Donnenberg MS, Kaper JB. Construction of an eae deletion mutant of enteropathogenic Escherichia coli by using a positive-selection suicide vector. Infect Immun 1991; 59:4310-7.
23. Derbise A, Lesic B, Dacheux D, Ghigo JM, Carniel E. A rapid and simple method for inactivating chromosomal genes in Yersinia. FEMS Immunology and Medical Microbiology 2003; 38:113-6. (Pubitemid 37297836)
24. Brinkmann V, Laube B, Abu Abed U, Goosmann C, Zychlinsky A. Neutrophil extracellular traps: how to generate and visualize them. J. Vis. Exp. 2010; 36:e1724.
25. Brodin P, Poquet Y, Levillain F, et al. High content phenotypic cellbased visual screen identifies Mycobacterium tuberculosis acyltrehalose-containing glycolipids involved in phagosome remodeling. PLoS Pathogens 2010; 6:e1001100.
26. Vuletic S, Dong W, Wolfbauer G, Tang C, Albers JJ. PLTP regulates STAT3 and NFkappaB in differentiated THP1 cells and human monocyte-derived macrophages. Biochimica et Biophysica Acta 2011; 1813: 1917-24.
27. Pujol C, Bliska JB. The ability to replicate in macrophages is conserved between Yersinia pestis and Yersinia pseudotuberculosis. Infection and Immunity 2003; 71:5892-9. (Pubitemid 37205642)
28. Markart P, Korfhagen TR, Weaver TE, Akinbi HT. Mouse lysozyme M is important in pulmonary host defense against Klebsiella pneumoniae infection. Am J Respir Crit Care Med 2004; 169:454-8. (Pubitemid 38187116)
29. Shevach EM. Immunofluorescence and Cell Sorting. Current Protocols in Immunology. John Wiley & Sons, Inc: New-York, 2002; 5:5.0.1-5.0.3.
30. Hinnebusch BJ, Perry RD, Schwan TG. Role of the Yersinia pestis hemin storage (hms) locus in the transmission of plague by fleas. Science 1996; 273:367-70. (Pubitemid 26250267)
31. Pujol C, Bliska JB. Turning Yersinia pathogenesis outside in: subversion of macrophage function by intracellular yersiniae. Clin Immunol 2005; 114:216-26. (Pubitemid 40255127)
32. Markart P, Faust N, Graf T, Na CL, Weaver TE, Akinbi HT. Comparison of the microbicidal and muramidase activities of mouse lysozyme M and P. Biochem J 2004; 380:385-92. (Pubitemid 38788109)
33. Boneca IG, Dussurget O, Cabanes D, et al. A critical role for peptidoglycan N-deacetylation in Listeria evasion from the host innate immune system. Proc Natl Acad Sci USA 2007; 104:997-1002. (Pubitemid 46154725)
34. Davis KM, Akinbi HT, Standish AJ, Weiser JN. Resistance to mucosal lysozyme compensates for the fitness deficit of peptidoglycan modifications by Streptococcus pneumoniae. PLoS Pathogens 2008; 4: e1000241.
35. Clarke AJ, Dupont C. O-acetylated peptidoglycan: its occurrence, pathobiological significance, and biosynthesis. Can J Microbiol 1992; 38:85-91.
36. Wang G, Maier SE, Lo LF, Maier G, Dosi S, Maier RJ. Peptidoglycan deacetylation in Helicobacter pylori contributes to bacterial survival by mitigating host immune responses. Infection and Immunity 2010; 78:4660-6.
37. Chain PS, Carniel E, Larimer FW, et al. Insights into the evolution of Yersinia pestis through whole-genome comparison with Yersinia pseudotuberculosis. Proc Natl Acad Sci USA 2004; 101:13826-31. (Pubitemid 39298492)
38. Simonet M, Riot B, Fortineau N, Berche P. Invasin production by Yersinia pestis is abolished by insertion of an IS200-like element within the inv gene. Infection and Immunity 1996; 64:375-9. (Pubitemid 26009381)
39. Sebbane F, Devalckenaere A, Foulon J, Carniel E, Simonet M. Silencing and reactivation of urease in Yersinia pestis is determined by one G residue at a specific position in the ureD gene. Infection and Immunity 2001; 69:170-6. (Pubitemid 32038313)
40. Skurnik M, Wolf-Watz H. Analysis of the yopA gene encoding the Yop1 virulence determinants of Yersinia spp. Mol Microbiol 1989; 3:517-29. (Pubitemid 19237672)
41. Hudson KJ, Bouton AH. Yersinia pseudotuberculosis adhesins regulate tissue-specific colonization and immune cell localization in a mouse model of systemic infection. Infection and Immunity 2006; 74:6487-90. (Pubitemid 44657431)
42. Guinet F, Ave P, Jones L, Huerre M, Carniel E. Defective innate cell response and lymph node infiltration specify Yersinia pestis infection. PLoS One 2008; 3:e1688.
43. Chauvaux S, Dillies MA, Marceau M, et al. In silico comparison of Yersinia pestis and Yersinia pseudotuberculosis transcriptomes reveals a higher expression level of crucial virulence determinants in the plague bacillus. Int J Med Microbiol 2011; 301:105-16.
44. Bengoechea JA, Brandenburg K, Seydel U, Diaz R, Moriyon I. Yersinia pseudotuberculosis and Yersinia pestis show increased outer membrane permeability to hydrophobic agents which correlates with lipopolysaccharide acyl-chain fluidity. Microbiology 1998; 144 (Pt 6):1517-26. (Pubitemid 28284528)
45. Rebeil R, Ernst RK, Gowen BB, Miller SI, Hinnebusch BJ. Variation in lipid A structure in the pathogenic yersiniae. Mol Microbiol 2004; 52:1363-73. (Pubitemid 38746310)
46. Weadge JT, Pfeffer JM, Clarke AJ. Identification of a new family of enzymes with potential O-acetylpeptidoglycan esterase activity in both Gram-positive and Gram-negative bacteria. BMC Microbiol 2005; 5:49.
47. Dillard JP, Hackett KT. Mutations affecting peptidoglycan acetylation in Neisseria gonorrhoeae and Neisseria meningitidis. Infection and Immunity 2005; 73:5697-705. (Pubitemid 41193005)
48. Salinger N, Kokona B, Fairman R, Okeke IN. The plasmid-encoded regulator activates factors conferring lysozyme resistance on enteropathogenic Escherichia coli strains. Appl Environ Microbiol 2009; 75:275-80.
49. Vadyvaloo V, Jarrett C, Sturdevant DE, Sebbane F, Hinnebusch BJ. Transit through the flea vector induces a pretransmission innate immunity resistance phenotype in Yersinia pestis. PLoS Pathogens 2010; 6:e1000783.
50. Simonet M, Falkow S. Invasin expression in Yersinia pseudotuberculosis. Infection and Immunity 1992; 60:4414-7.